Michael Nofi - 10 Nov 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Chief Financial Officer
Signature
/s/ John R. Moore, Attorney-in-Fact for Michael Nofi
Issuer symbol
EWTX
Transactions as of
10 Nov 2025
Transactions value $
$0
Form type
4
Filing time
13 Nov 2025, 18:03:07 UTC
Previous filing
02 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nofi Michael Chief Financial Officer 1715 38TH STREET, BOULDER /s/ John R. Moore, Attorney-in-Fact for Michael Nofi 13 Nov 2025 0001705477

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Restricted Stock Units Award $0 +43.8K $0.00 43.8K 10 Nov 2025 Common Stock 43.8K $0.00 Direct F1
transaction EWTX Stock Options (Right to buy) Award $0 +263K $0.00 263K 10 Nov 2025 Common Stock 263K $18.28 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on November 10, 2026.
F2 1/4th of the shares subject to the option become vested and exercisable on November 10, 2026 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.